Advances in molecular analysis of fragile X syndrome.

Fragile X syndrome is a common cause of mental retardation that is inherited as an X-linked dominant disorder with reduced penetrance. Fragile X syndrome has been shown to be caused by an unstable CGG repeat within the fragile X mental retardation-1 (FMR1) gene. The repeat is normally polymorphic with six to 52 repeats, while affected males and females exhibit a massive expansion resulting in 230 to more than 1000 repeats. Such expansions, called "full mutations," are associated with abnormal methylation of the FMR1 gene leading to transcriptional suppression. The resulting absence of the encoded protein, FMRP, a cytosolic RNA-binding protein, is believed to result in the phenotype. Nonpenetrant male carriers and many female carriers exhibit premutation alleles of intermediate length (50 to 230 repeats), which are normally expressed. Male carriers transmit only unstable premutations while female premutation carriers can have carrier offspring with premutations or affected children with full mutations. The risk of having an affected child is directly related to the number of maternal repeats, with sequentially increasing probabilities of these alleles converting to full mutations as they are transmitted to subsequent generations. Advances have led to highly accurate laboratory diagnoses of both carrier and affected individuals as well as markedly improved prenatal diagnosis. In addition, a previously unrecognized class of mutation, later found responsible for several other important genetic diseases, has emerged.

[1]  S. Thibodeau,et al.  Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. , 1993, American journal of human genetics.

[2]  D. Loesch,et al.  Genotype-phenotype relationships in fragile X syndrome: a family study. , 1993, American journal of human genetics.

[3]  C. Mathew,et al.  Cytogenetic versus DNA diagnosis in routine referrais for fragile X syndrome , 1993, The Lancet.

[4]  S. Warren,et al.  FMR1 protein: conserved RNP family domains and selective RNA binding. , 1993, Science.

[5]  W. Brown,et al.  Rapid Fragile X Carrier Screening and Prenatal Diagnosis Using a Nonradioactive PCR Test , 1993 .

[6]  D. Nelson,et al.  High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. , 1993, Human molecular genetics.

[7]  W. Brown,et al.  Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. , 1993, American journal of human genetics.

[8]  D. Nelson,et al.  Trinucleotide repeat expansions in neurological disease , 1993, Current Opinion in Neurobiology.

[9]  J. D. Thompson,et al.  KH domains within the FMR1 sequence suggest that fragile X syndrome stems from a defect in RNA metabolism. , 1993, Trends in biochemical sciences.

[10]  J. Mandel,et al.  The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.

[11]  E. Eichler,et al.  Fine structure of the human FMR1 gene. , 1993, Human molecular genetics.

[12]  R. Nussbaum,et al.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein , 1993, Cell.

[13]  K. Davies,et al.  Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation , 1993, Cell.

[14]  Huda Y. Zoghbi,et al.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.

[15]  E. Eichler,et al.  Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG–repeat , 1993, Nature Genetics.

[16]  L. Surh,et al.  Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene , 1993, Nature Genetics.

[17]  B. Oostra,et al.  Characterization and localization of the FMR-1 gene product associated with fragile X syndrome , 1993, Nature.

[18]  B. Oostra,et al.  The full mutation in the FMR–1 gene of male fragile X patients is absent in their sperm , 1993, Nature Genetics.

[19]  D. Nelson,et al.  Trinucleotide repeat instability: when and where? , 1993, Nature Genetics.

[20]  W. Vogel,et al.  Mitotic stability of fragile X mutations in differentiated cells indicates early post–conceptional trinucleotide repeat expansion , 1993, Nature Genetics.

[21]  J. Mandel,et al.  Origin of the expansion mutation in myotonic dystrophy , 1993, Nature Genetics.

[22]  R. Gibbs,et al.  Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. , 1993, Science.

[23]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[24]  S. Warren,et al.  The fragile X syndrome: no evidence for any recent mutations. , 1993, Journal of medical genetics.

[25]  R. Saul,et al.  Molecular genetic advances in fragile X syndrome. , 1993, The Journal of pediatrics.

[26]  J. Mandel,et al.  Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes. , 1993, American journal of human genetics.

[27]  J. Mandel,et al.  Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. , 1992, Journal of medical genetics.

[28]  G. Riggins,et al.  Human genes containing polymorphic trinucleotide repeats , 1992, Nature Genetics.

[29]  R. Hansen,et al.  Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. , 1992, Human molecular genetics.

[30]  J. Sutcliffe,et al.  DNA methylation represses FMR-1 transcription in fragile X syndrome. , 1992, Human molecular genetics.

[31]  A. Poustka,et al.  Fragile X syndrome without CCG amplification has an FMR1 deletion , 1992, Nature Genetics.

[32]  A. Poustka,et al.  A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. , 1992, American journal of human genetics.

[33]  R. Richards,et al.  Anticipation legitimized: unstable DNA to the rescue. , 1992, American journal of human genetics.

[34]  K. Friend,et al.  Evidence of founder chromosomes in fragile X syndrome , 1992, Nature Genetics.

[35]  M. Butler,et al.  Standards for selected anthropometric measurements in males with the fragile X syndrome. , 1992, Pediatrics.

[36]  G. Sutherland,et al.  Characterisation of a new rare fragile site easily confused with the fragile X. , 1992, Human molecular genetics.

[37]  D. Loesch,et al.  Fragile-X syndrome: unique genetics of the heritable unstable element. , 1992, American journal of human genetics.

[38]  J. Mandel,et al.  Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. , 1992, American journal of medical genetics.

[39]  T. Ashizawa,et al.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy. , 1992, Science.

[40]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[41]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[42]  L. Kornman,et al.  Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. , 1991, The New England journal of medicine.

[43]  N. Tommerup,et al.  Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. , 1991, The New England journal of medicine.

[44]  S. Knight,et al.  Molecular heterogeneity of the fragile X syndrome. , 1991, Nucleic acids research.

[45]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[46]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[47]  R I Richards,et al.  Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n , 1991, Science.

[48]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[49]  D. Schlessinger,et al.  Fragile X genotype characterized by an unstable region of DNA , 1991, Science.

[50]  J. Mandel,et al.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome , 1991, Science.

[51]  M. Butler,et al.  A 15‐item checklist for screening mentally retarded males for the fragile X syndrome , 1991, Clinical genetics.

[52]  K. Davies,et al.  Physical mapping across the fragile X: Hypermethylation and clinical expression of the fragile X syndrome , 1991, Cell.

[53]  C. Petit,et al.  Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis , 1991, Nature.

[54]  M. Butler,et al.  Anthropometric comparison of mentally retarded males with and without the fragile X syndrome. , 1991, American journal of medical genetics.

[55]  Brown Wt The fragile X: progress toward solving the puzzle. , 1990 .

[56]  A. Hockey,et al.  Early manifestations of the Martin-Bell syndrome based on a series of both sexes from infancy. , 1988, American journal of medical genetics.

[57]  J. Fryns,et al.  A peculiar subphenotype in the fra(X) syndrome: extreme obesity‐short stature‐stubby hands and feet‐diffuse hyperpigmentation. Further evidence of disturbed hypothalamic function in the fra(X) syndrome? , 1987, Clinical genetics.

[58]  G. Turner,et al.  Preventive screening for the fragile X syndrome. , 1986, The New England journal of medicine.

[59]  N. Morton,et al.  The marker (X) syndrome: a cytogenetic and genetic analysis , 1984, Annals of human genetics.

[60]  G. Turner,et al.  X-linked mental retardation, macro-orchidism, and the Xq27 fragile site. , 1980, The Journal of pediatrics.

[61]  Sutherland Gr Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture. , 1979 .

[62]  G. Sutherland Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. , 1977, Science.

[63]  H. Lubs A marker X chromosome. , 1969, American journal of human genetics.

[64]  V. McKusick Mendelian Inheritance in Man: Catalogs of Autosomal Dominant, Autosomal Recessive, and X-Linked Phenotypes , 1983 .

[65]  J. Bell,et al.  A PEDIGREE OF MENTAL DEFECT SHOWING SEX-LINKAGE , 1943, Journal of neurology and psychiatry.

[66]  A. Sano,et al.  Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p , 1994, Nature Genetics.

[67]  O. Onodera,et al.  Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.

[68]  Edwin Reyniers,et al.  A point mutation in the FMR-1 gene associated with fragile X mental retardation , 1993, Nature Genetics.

[69]  D. Ledbetter,et al.  Fragile X syndrome: a unique mutation in man. , 1986, Annual review of genetics.

[70]  T. Webb,et al.  Population incidence and segregation ratios in the Martin-Bell syndrome. , 1986, American journal of medical genetics.

[71]  R. Hagerman,et al.  Aortic root dilatation and mitral valve prolapse in the fragile X syndrome. , 1986, American journal of medical genetics.